Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Simvastatin-induced decline in cognition.

Kalpana P Padala1, Prasad R Padala, Jane F Potter

  • 1Geriatrics Section, Department of Internal Medicine, 981320 Nebraska Medical Center, Omaha, NE 68198-1320, USA. kpadala@unmc.edu

The Annals of Pharmacotherapy
|August 31, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Uncovering lipid biomarkers linked to methylphenidate efficacy in treating apathy in Alzheimer's disease: insights from the ADMET 2 trial.

Alzheimer's research & therapy·2026
Same author

Cognitive and Emotional Resilience Seven Years After Brain Tumor Resection.

Cureus·2026
Same author

Lessons Learnt From COVID-19 Vaccine Hesitancy: The Role of Culturally Concordant Providers.

Cureus·2026
Same author

Post COVID-19 waitlist reduction in a memory disorder clinic.

Frontiers in health services·2026
Same author

Peripheral biomarkers associated with apathy and predicting response to methylphenidate: Secondary analysis of the Apathy in Dementia Methylphenidate Trial 2 (ADMET2) study.

International psychogeriatrics·2026
Same author

Enhancing Advance Care Planning in Primary Care: A Three-Year Implementation Study in Nebraska.

Journal of the American Geriatrics Society·2025

Simvastatin therapy may worsen cognitive function in older adults, particularly those with existing memory issues. Discontinuation and careful monitoring are recommended for patients experiencing adverse cognitive effects.

Area of Science:

  • Geriatric Medicine
  • Pharmacology
  • Neuroscience

Background:

  • Statins, including simvastatin, are widely prescribed for cardiovascular disease prevention in older adults.
  • Cognitive side effects of statins are a recognized but not fully understood phenomenon.
  • Prevalence of cognitive impairment increases with age, necessitating careful drug evaluation in this population.

Observation:

  • A 64-year-old male patient initiated on simvastatin 40 mg/day developed acute cognitive difficulties within one week.
  • Neuropsychological assessments revealed a decline in Mini-Mental State Exam (MMSE) scores and functional abilities.
  • Cognitive function returned to baseline after simvastatin discontinuation and rapidly declined again upon rechallenge.

Findings:

  • The patient experienced worsening short-term memory, long-term memory, and item misplacement attributed to simvastatin.

Related Experiment Videos

  • Standardized instruments documented a clear association between simvastatin use and cognitive decline.
  • The Naranjo probability scale indicated a highly probable adverse reaction to simvastatin.

    • Implications:

    • Simvastatin may exacerbate pre-existing cognitive deficits and precipitate new ones in older individuals.
    • Clinicians should exercise caution when prescribing statins to elderly patients, especially those with baseline memory problems.
    • Further research is warranted to elucidate the mechanisms and identify risk factors for statin-induced cognitive impairment.